OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
September 13, 2023
IATA statistics suggest improvement over recent months.
September 12, 2023
How drugmakers can navigate the program’s pricing challenges and regulatory developments.
September 08, 2023
Conditions require a disciplined approach to drug pricing.
September 07, 2023
Novo Nordisk receives the full rights to develop and commercialize the lead program.
Pharma Commerce provides a synopsis of the presentation.
September 06, 2023
Biopharma company now required to seek approval before attempting further buyouts.
Stakeholders uncover the obstacles surrounding the industry onboarding process.
September 05, 2023
Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.
Attendees meet to discuss operational issues related to traceability implementation.
Alexion – AstraZeneca Rare Disease, GSK, Novartis, Pfrizer, and Zoetis will join the newly established life sciences platform.